공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 희귀의약품 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년)

Orphan Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028792
페이지 정보 영문 175 Pages
가격
US $ 5,000 ₩ 5,987,000 PDF (Single User License)
US $ 7,500 ₩ 8,981,000 PDF (Site License)
US $ 10,000 ₩ 11,975,000 PDF (Enterprise License)


세계의 희귀의약품 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년) Orphan Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 희귀의약품(Orphan Drugs) 시장의 구조와 동향에 대해 분석했으며, 시장의 주요 특징과 구조, 전체적인 시장 규모·성장률 동향 전망, 치료 영역별·지역별·주요 국가별 상세 동향, 주요 기업 개요, 최근의 주요 동향, 향후 시장 기회 등에 대해 전해드립니다.

목차

제1장 개요

제2장 희귀의약품 시장의 특징

제3장 희귀의약품 시장 동향과 전략

제4장 희귀의약품 시장에 대한 코로나19(COVID-19)의 영향

제5장 희귀의약품 시장 : 시장 규모 및 성장률

  • 시장 규모(단위 : 10억 달러, 2015-2020년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 시장 규모(단위 : 10억 달러, 2020-2025년, 2030년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 희귀의약품 시장 : 분야별 분석

  • 치료 영역별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 종양
  • 혈액
  • 중추신경계
  • 내분비
  • 심혈관
  • 호흡기
  • 면역조절
  • 유통 채널별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 병원 약국
  • 소매 약국
  • 온라인 판매
  • 의약품 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 생물제제
  • 비생물제제
  • 질환 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 종양
  • 혈액질환
  • 신경질환
  • 심혈관질환
  • 기타

제7장 희귀의약품 시장 : 지역별/국가별 분석

  • 지역별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 국가별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제8장 아시아태평양의 희귀의약품 시장

  • 시장 개요
  • 지역 정보
  • 치료 영역별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽의 희귀의약품 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 동유럽의 희귀의약품 시장

제20장 러시아 시장

제21장 북미의 희귀의약품 시장

제22장 미국 시장

제23장 남미의 희귀의약품 시장

제24장 브라질 시장

제25장 중동의 희귀의약품 시장

제26장 아프리카의 희귀의약품 시장

제27장 희귀의약품 시장 : 경쟁 구도와 기업 개요

  • 경쟁 구도
  • 기업 개요
    • Bristol-Myers Squibb Company
    • Celgene Corporation
    • F. Hoffmann-La Roche Ltd
    • Amgen
    • Biogen

제28장 희귀의약품 파이프라인 제품 분석

제29장 희귀의약품 시장의 주요 인수합병(M&A)

제30장 희귀의약품 시장 : 전망과 잠재력 분석

제31장 부록

LSH 21.09.30

“Orphan Drugs Global Market Report 2021: COVID-19 Growth And Change to 2030” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global orphan drugs market.

This report focuses on orphan drugs market which is experiencing strong growth. The report gives a guide to the orphan drugs market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the orphan drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Orphan Drugs market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider orphan drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The orphan drugs market section of the report gives context. It compares the orphan drugs market with other segments of the orphan drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, orphan drugs indicators comparison.

Scope

Markets Covered:

1) By Therapy Area: Oncology; Blood; Central Nervous System; Endocrine; Cardiovascular; Respiratory; Immunomodulatory

2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Sales

3) By Drug Type: Biological; Non-Biological

4) By Diesease Type: Oncology; Hematology; Neurology; Cardiovascular; Others

Companies Mentioned: Bristol-Myers Squibb Company; Celgene Corporation; F. Hoffmann-La Roche Ltd; Amgen; Biogen

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Orphan Drugs Market Characteristics

3. Orphan Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Orphan Drugs

5. Orphan Drugs Market Size And Growth

  • 5.1. Global Orphan Drugs Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Orphan Drugs Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Orphan Drugs Market Segmentation

  • 6.1. Global Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oncology
  • Blood
  • Central Nervous System
  • Endocrine
  • Cardiovascular
  • Respiratory
  • Immunomodulatory
  • 6.2. Global Orphan Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • 6.3. Global Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Biological
  • Non-Biological
  • 6.4. Global Orphan Drugs Market, Segmentation By Diesease Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oncology
  • Hematology
  • Neurology
  • Cardiovascular
  • Others

7. Orphan Drugs Market Regional And Country Analysis

  • 7.1. Global Orphan Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Orphan Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Orphan Drugs Market

  • 8.1. Asia-Pacific Orphan Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Orphan Drugs Market

  • 9.1. China Orphan Drugs Market Overview
  • 9.2. China Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Orphan Drugs Market

  • 10.1. India Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Orphan Drugs Market

  • 11.1. Japan Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Orphan Drugs Market

  • 12.1. Australia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Orphan Drugs Market

  • 13.1. Indonesia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Orphan Drugs Market

  • 14.1. South Korea Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Orphan Drugs Market

  • 15.1. Western Europe Orphan Drugs Market Overview
  • 15.2. Western Europe Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Orphan Drugs Market

  • 16.1. UK Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Orphan Drugs Market

  • 17.1. Germany Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Orphan Drugs Market

  • 18.3. France Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Orphan Drugs Market

  • 19.1. Eastern Europe Orphan Drugs Market Overview
  • 19.2. Eastern Europe Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Orphan Drugs Market

  • 20.1. Russia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Orphan Drugs Market

  • 21.1. North America Orphan Drugs Market Overview
  • 21.2. North America Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Orphan Drugs Market

  • 22.1. USA Orphan Drugs Market Overview
  • 22.2. USA Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Orphan Drugs Market

  • 23.1. South America Orphan Drugs Market Overview
  • 23.2. South America Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Orphan Drugs Market

  • 24.1. Brazil Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Orphan Drugs Market

  • 25.1. Middle East Orphan Drugs Market Overview
  • 25.2. Middle East Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Orphan Drugs Market

  • 26.1. Africa Orphan Drugs Market Overview
  • 26.2. Africa Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Orphan Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Orphan Drugs Market Competitive Landscape
  • 27.2. Orphan Drugs Market Company Profiles
    • 27.2.1. Bristol-Myers Squibb Company
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Celgene Corporation
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. F. Hoffmann-La Roche Ltd
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Amgen
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Biogen
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Orphan Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Orphan Drugs Market

30. Orphan Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q